North America Quantitative Structure-Activity Relationship Market to Grow at a CAGR of 4.2% to reach US$ 786.6 million Million from 2020 to 2027
The quantitative structure-activity relationship market in North America is expected to grow from US$ 590.2 million in 2020 to US$ 786.6 million by 2027; it is estimated to grow at a CAGR of 4.2% from 2020 to 2027.
The quantitative structure-activity relationship is a computational modelling method used for revealing relationships between structural properties of chemical compounds and biological activities. The drug discovery and development with potential therapeutic applications is a complicated, expensive, and time-consuming venture, for which various computational methodologies such as QSAR have been adopted to increase the efficiency of drug discovery. From hit identification to lead optimization, techniques such as a ligand or structure-based virtual screening are widely being used by various pharmaceutical companies. With the help of modelling, existing data can be leveraged to gain product safety and effectiveness insights. Owing to the efficiency of computational methods, the FDA and EMA have incorporated drug modelling to achieve efficient drug development. In addition, in-Silico design (computer-aided) is being utilized to expedite and facilitate hit identification, optimize the distribution, absorption, metabolism, and toxicity profile to avoid safety issues. Commonly used in-silico approaches include ligand-based structure-based drug design, drug design, and quantitative structure-activity relationships. As these methods are faster and provide valuable insights into experimental findings and mechanisms of action, various pharmaceutical companies have started adopting these techniques for better outcomes.
The first of the National Institute of Allergy and Infectious Diseases’ (NIAID) Covid-19 research priorities is to improve understanding of the disease and the novel coronavirus that causes it, SARS-CoV-2. This helps with understanding the transmission of the disease, including determining whether it is likely to be seasonally circulating, as well as why Covid-19 so dramatically affects some individuals, while others remain asymptomatic. But better knowledge about the virus and the disease can also support the identification of new drug targets or which existing drugs could help tackle this viral disease. Drugs are essential to stopping more suffering at the hands of Covid-19; at the time of writing, more than 461,000 people have tragically died from the disease in the US. The most critical method for anti-SARS-CoV-2 drug discovery includes the de novo development of new, specific drugs based upon the genomic and biophysical understanding of this virus. For instance, the determination of key SARS-CoV-2 targets may bring about the production of siRNA molecules or inhibitors against specific viral enzymes correlated with viral replication. The intensive vaccines and potential immunity boosting drug development procedures and ramping up of food testing services, which is expected to create a positive impact on the growth of quantitative structure-activity relationship (QSAR) market in the North American region.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the quantitative structure-activity relationships market. The North America quantitative structure-activity relationships market is expected to grow at a good CAGR during the forecast period.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
North America Quantitative Structure-Activity Relationship Market Segmentation
By Application
- Drug Discovery
- Molecular Modelling
- Chemical Screening
- Regulatory and Decision-Making
- Others
By End User
- Pharmaceuticals
- Cosmetics
- Environmental
- Food and Beverage
By Country
North America
- US
- Canada
- Mexico
Companies Mentioned
- ProtoQSAR SL
- Intertek Group Plc
- Laboratory Corporation of America Holdings
- LATHAM BIOPHARM GROUP
- NSF INTERNATIONAL.
- Creative Biolabs
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Quantitative Structure-Activity Relationship Market – By Application
1.3.2 Quantitative Structure-Activity Relationship Market – By Industry
1.3.3 North America Quantitative Structure-Activity Relationship Market – By Country
2. North America Quantitative Structure-Activity Relationship Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Quantitative Structure-Activity Relationship Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Quantitative Structure-Activity Relationship Market- North America PEST Analysis
4.3 Expert Opinion
5. North America Quantitative Structure-Activity Relationship Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Adoption of Modelling Tools in Drug Discovery
5.1.2 Increasing Economic Burden of Drug Discovery
5.2 Market Restraints
5.2.1 Less Adoption in Emerging Countries
5.3 Market Opportunities
5.3.1 Market Players Initiatives
5.4 Future Trends
5.4.1 Growing Adoption of QSAR and Artificial Intelligence in Drug Discovery
5.5 Impact Analysis
6. Quantitative Structure-Activity Relationship Market – North America Analysis
6.1 North America Quantitative Structure-Activity Relationship Market Revenue Forecasts and Analysis
7. North America Quantitative Structure-Activity Relationship Market Analysis And Forecasts To 2027 – By Application
7.1 Overview
7.2 Quantitative Structure-Activity Relationship (QSAR) Market, by Application, 2019 and 2027 (%)
7.3 Drug Discovery
7.3.1 Overview
7.3.2 Drug Discovery Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Molecular Modelling
7.4.1 Overview
7.4.2 Molecular Modelling Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Chemical Screening
7.5.1 Overview
7.5.2 Chemical Screening Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Regulatory and Decision-Making
7.6.1 Overview
7.6.2 Regulatory and Decision-Making Market Revenue and Forecasts to 2027 (US$ Mn)
7.7 Others
7.7.1 Overview
7.7.2 Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. North America Quantitative Structure-Activity Relationship Market Analysis And Forecasts To 2027– By Industry
8.1 Overview
8.2 Quantitative Structure-Activity Relationship (QSAR) Market, by Industry, 2019 and 2027 (%)
8.3 Pharmaceuticals
8.3.1 Overview
8.3.2 Pharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Cosmetics
8.4.1 Overview
8.4.2 Cosmetics Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Environmental
8.5.1 Overview
8.5.2 Environmental Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Food and Beverage
8.6.1 Overview
8.6.2 Food and Beverage Market Revenue and Forecasts to 2027 (US$ Mn)
9. Quantitative Structure-Activity Relationship Market Revenue and Forecasts to 2027 – Geographical Analysis
9.1 North America: Quantitative Structure-Activity Relationship (QSAR) Market
9.1.1 Overview
9.1.2 North America: Quantitative Structure-Activity Relationship (QSAR) Market, by Country, 2019 & 2027 (%)
9.1.2.1 US: Quantitative Structure-Activity Relationship (QSAR) Market – Revenue and Forecast to 2027 (USD Million)
9.1.2.1.1 US: Quantitative Structure-Activity Relationship (QSAR) Market – Revenue and Forecast to 2027 (USD Million)
9.1.2.1.2 US: Quantitative Structure-Activity Relationship (QSAR) Market, by Application– Revenue and Forecast to 2027 (USD Million)
9.1.2.1.3 US: Quantitative Structure-Activity Relationship (QSAR) Market, by Industry– Revenue and Forecast to 2027 (USD Million)
9.1.2.2 Canada: Quantitative Structure-Activity Relationship (QSAR) Market – Revenue and Forecast to 2027 (USD Million)
9.1.2.2.1 Canada: Quantitative Structure-Activity Relationship (QSAR) Market – Revenue and Forecast to 2027 (USD Million)
9.1.2.2.2 Canada: Quantitative Structure-Activity Relationship (QSAR) Market, by Application– Revenue and Forecast to 2027 (USD Million)
9.1.2.2.3 Canada: Quantitative Structure-Activity Relationship (QSAR) Market, by Industry– Revenue and Forecast to 2027 (USD Million)
9.1.2.3 Mexico: Quantitative Structure-Activity Relationship (QSAR) Market – Revenue and Forecast to 2027 (USD Million)
9.1.2.3.1 Mexico: Quantitative Structure-Activity Relationship (QSAR) Market – Revenue and Forecast to 2027 (USD Million)
9.1.2.3.2 Mexico: Quantitative Structure-Activity Relationship (QSAR) Market, by Application– Revenue and Forecast to 2027 (USD Million)
9.1.2.3.3 Mexico: Quantitative Structure-Activity Relationship (QSAR) Market, by Industry– Revenue and Forecast to 2027 (USD Million)
10. Impact of COVID-19 Pandemic on North America Quantitative Structure-Activity Relationship Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 ProtoQSAR SL
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Intertek Group Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Laboratory Corporation of America Holdings
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 LATHAM BIOPHARM GROUP.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 NSF INTERNATIONAL.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Creative Biolabs
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. US: Quantitative Structure-Activity Relationship (QSAR) Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 2. US: Quantitative Structure-Activity Relationship (QSAR) Market, by Industry – Revenue and Forecast to 2027 (USD Million)
Table 3. Canada: Quantitative Structure-Activity Relationship (QSAR) Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 4. Canada: Quantitative Structure-Activity Relationship (QSAR) Market, by Industry – Revenue and Forecast to 2027 (USD Million)
Table 5. Mexico: Quantitative Structure-Activity Relationship (QSAR) Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 6. Mexico: Quantitative Structure-Activity Relationship (QSAR) Market, by Industry – Revenue and Forecast to 2027 (USD Million)
Table 7. Organic Developments Done By Companies
Table 8. Inorganic Developments Done By Companies
Table 9. Glossary of Terms, Quantitative Structure-Activity Relationship Market
LIST OF FIGURES
Figure 1. Quantitative Structure-Activity Relationship Market Segmentation
Figure 2. North America Quantitative Structure-Activity Relationship Market Overview
Figure 3. Drug Discovery Segment Held Largest Share of Application in Quantitative Structure-Activity Relationship Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Quantitative Structure-Activity Relationship Market - North America PEST Analysis
Figure 6. Quantitative Structure-Activity Relationship Market Impact Analysis of Driver and Restraints
Figure 7. North America Quantitative Structure-Activity Relationship Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 8. Quantitative Structure-activity Relationship (QSAR) Market breakdown, by Application, 2019 and 2027 (%)
Figure 9. Drug Discovery Market Revenue And Forecasts to 2027 (US$ Mn)
Figure 10. Molecular Modelling Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. Chemical Screening Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Regulatory and Decision-Making Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Quantitative Structure-Activity Relationship (QSAR) Market breakdown, by, 2019 and 2027 (%)
Figure 15. Pharmaceuticals Market Revenue And Forecasts to 2027 (US$ Mn)
Figure 16. Cosmetics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. Environmental Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Food and Beverage Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. North America: Quantitative Structure-Activity Relationship (QSAR) Market, by Key Country – Revenue (2019) (USD Million)
Figure 20. North America: Quantitative Structure-Activity Relationship (QSAR) Market, by Country, 2019 & 2027 (%)
Figure 21. US: Quantitative Structure-Activity Relationship (QSAR) Market – Revenue and Forecast to 2027 (USD Million)
Figure 22. Canada: Quantitative Structure-Activity Relationship (QSAR) Market – Revenue and Forecast to 2027 (USD Million)
Figure 23. Mexico: Quantitative Structure-Activity Relationship (QSAR) Market – Revenue and Forecast to 2027 (USD Million)
Figure 24. Impact of COVID-19 Pandemic in North American Country Markets
Figure 25. Growth Strategies Done by the Companies in the Market, (%)
- ProtoQSAR SL
- Intertek Group Plc
- Laboratory Corporation of America Holdings
- LATHAM BIOPHARM GROUP
- NSF INTERNATIONAL.
- Creative Biolabs
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For